Breaking the picomolar barrier in lateral flow assays using Bright-Dtech___ 614 -- Europium nanoparticles for enhanced sensitivity

Juliette Lajoux, Yulieth D Banguera-Ordoñez, Amadeo Sena-Torralba +5

Lateral flow immunoassays (LFIA) are among the most widely used rapid diagnostic tests for point-of-care screening of disease biomarkers. However, their limited sensitivity hinders…